Chi Sheng Pharma & Biotech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Chi Sheng Pharma & Biotech Co Ltd

Watchlist Manager

Watchlist

Price: 28.75 TWD -0.86% Market Closed

Market Cap: NT$1.7B

C	Chi Sheng Pharma & Biotech Co Ltd TPEX:4111	TW
V	Voksel Electric Tbk PT IDX:VOKS	ID
	Oceanic Iron Ore Corp XTSX:FEO	CA

Profitability Summary

Chi Sheng Pharma & Biotech Co Ltd's profitability score is 57/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

36%

Gross Margin is Increasing

34% > 39%

Healthy Operating Margin

14%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

8% > 14%

Healthy Net Margin

13%

Low 3Y Average Net Margin

10%

Net Margin is Increasing

11% > 13%

Exceptional Free Cash Flow Margin

15%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

57 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.